Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
187 studies found for:    "Poliomyelitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Poliomyelitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis Vaccine (Sabin strains)
2 Completed The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis Vaccine (Sabin strains);   Biological: Oral Poliomyelitis Vaccine;   Biological: Inactivated Poliomyelitis Vaccine (Salk strains).
3 Completed The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis Vaccine (Sabin strains);   Biological: Inactivated Poliomyelitis Vaccine (Salk strains)
4 Completed The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)
Condition: Poliomyelitis
Interventions: Biological: Live attenuated Poliomyelitis vaccine (Human Diploid Cell);   Biological: Live attenuated Poliomyelitis vaccine (Monkey Kidney Cell)
5 Completed Safety of Imovax Polio in Chinese Infants and Children
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis vaccine
6 Completed Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix™) in Infants
Condition: Poliomyelitis
Intervention: Biological: Poliorix™
7 Completed Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine
Condition: Poliomyelitis
Interventions: Biological: TiantanBio bOPV lot 1;   Biological: TiantanBio bOPV lot 2;   Biological: Bivalent Type 1 & 3 Oral Poliomyelitis Vaccine (BioFarma)
8 Completed Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine
Conditions: Polio;   Poliomyelitis
Interventions: Biological: Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio;   Biological: Live oral poliovirus type 1, 2 and 3
9 Completed Immunogenicity and Safety of 3 Adjuvated Reduced Dose Inactivated Polio Vaccines (IPV-Al SSI) and Non-adjuvated Full Dose IPV SSI, Given as Primary Vaccinations to Infants at 6, 10 and 14 Weeks of Age
Condition: Poliomyelitis
Interventions: Biological: Primary series of immunisation comprised by 3 vaccinations IPV-Al SSI;   Biological: IPV Vaccine SSI
10 Completed Immunogenicity of Inactivated and Live Polio Vaccines
Condition: Poliomyelitis
Interventions: Biological: Group A: Trivalent Oral Polio Vaccine;   Biological: Group B: Bivalent Oral Polio Vaccine;   Biological: Group C: Inactivated Polio Vaccine;   Biological: Group D: fractional IPV (f-IPV);   Biological: Arm E: f-IPV and bOPV
11 Completed Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
Condition: Poliomyelitis
Interventions: Biological: Vaccination with inactivated polio vaccine;   Procedure: Collection of serum
12 Completed Polio End-game Strategies - Poliovirus Type 2 Challenge Study
Condition: Poliomyelitis
Interventions: Biological: IPV;   Biological: bOPV;   Biological: bOPV and IPV;   Biological: bOPV and IPV and IPV2;   Biological: tOPV
13 Completed A Study of the Safety of IMOVAX Polio™ in China
Conditions: Poliomyelitis;   Polio
Intervention: Biological: IMOVAX Polio™-Inactivated types 1, 2, and 3 poliovirus D vaccine
14 Completed Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
Condition: Poliomyelitis
Interventions: Drug: Zinc Sulfate;   Drug: Placebo
15 Completed A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China
Conditions: Polio;   Poliomyelitis
Intervention: Biological: IMOVAX Polio™: Inactivated Poliomyelitis Vaccine
16 Completed
Has Results
Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan
Conditions: Poliomyelitis;   Polio
Intervention: Biological: IMOVAX POLIO®: Inactive Poliovirus Vaccine
17 Completed Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis vaccine (IMOVAX)
18 Completed Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated types 1, 2, and 3 poliovirus, D antigens
19 Completed Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine
Condition: Poliomyelitis
Intervention: Biological: poliovirus vaccine
20 Completed Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
Condition: Poliomyelitis
Interventions: Drug: IPV;   Drug: Sabin-IPV;   Drug: Adjuvanted Sabin-IPV

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.